Login
Enter your username or email address
Enter the password that accompanies your username.

Request new password

product logo

Brainmaster country menu

  • Home
  • Brain Master
  • Ask the Experts

Back to video list Back to Home

If optimizing the dose of the current antidepressant is not an effective strategy, at which part of the dose range can we consider adding an augmenting agent?

You may also like

Parkinson's Disease
Article

Biomarkers – ever closer in PD

Depression Bipolar
Article

Inflammatory biomarkers in mood disorders and implications for treatment

Alzheimer's Disease
Article

High Mobility Group Box 1 (HMGB1) in Vascular Dementia: Mechanism, Biomarker Potential, and Therapeutic Implication

Alzheimer's Disease
Article

Addressing challenges of dosage and administration in the development of disease-modifying therapy

Progress in Mind South East Asia

HCP Access Verification Required

To gain access, please provide details to verify you are a healthcare professional.

Register Login

If you are not located in South East Asia click here.

Brought to you by

Lundbeck

© 2022 Brain Master

SEA Brain Master

Disclaimer and privacy statement

Live webinars are hosted on third party platforms

Register as a health care professional

Login as a registered health care professional

Please enter your email to continue